According to a previous report, people with ALDH2*2 variants have higher risks of head and neck and esophageal cancers, because the ALDH2 activity in their tissues is much lower compared to that in the gastrointestinal tissues of healthy people [22]. This evidence concerns the gene ALDH2 and esophageal cancer.